AAAAAA
Results: 326-350/1162
Authors:
Slob, AK
Citation: Ak. Slob, Age, libido, and male sexual function, PROSTATE, 2000, pp. 9-13
Authors:
Ekman, P
Citation: P. Ekman, The prostate as an endocrine organ: Androgens and estrogens, PROSTATE, 2000, pp. 14-18
Authors:
Van Cangh, PJ
Gala, JL
Tombal, B
Citation: Pj. Van Cangh et al., Immediate vs. delayed androgen deprivation for prostate cancer, PROSTATE, 2000, pp. 19-25
Authors:
Schroder, FH
Citation: Fh. Schroder, Endocrine treatment: Expected duration stage by stage, PROSTATE, 2000, pp. 26-31
Authors:
Hedlund, PO
Citation: Po. Hedlund, Side effects of endocrine treatment and their mechanisms: Castration, antiandrogens, and estrogens, PROSTATE, 2000, pp. 32-37
Authors:
Stege, R
Citation: R. Stege, Potential side-effects of endocrine treatment of long duration in prostatecancer, PROSTATE, 2000, pp. 38-42
Authors:
Griffiths, K
Denis, LJ
Citation: K. Griffiths et Lj. Denis, Exploitable mechanisms for the blockade of androgenic action, PROSTATE, 2000, pp. 43-51
Authors:
Klein, RD
Maliner-Jongewaard, MS
Udayakumar, TS
Boyd, JL
Nagle, RB
Bowden, GT
Citation: Rd. Klein et al., Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell line LNCaP but not in normal primary prostate epithelial cells, PROSTATE, 41(4), 1999, pp. 215-223
Authors:
Negri-Cesi, P
Colciago, A
Poletti, A
Motta, M
Citation: P. Negri-cesi et al., 5 alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3, PROSTATE, 41(4), 1999, pp. 224-232
Authors:
Planz, B
Aretz, HT
Wang, QF
Tabatabaei, S
Kirley, SD
Lin, CW
McDougal, WS
Citation: B. Planz et al., Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor, PROSTATE, 41(4), 1999, pp. 233-242
Authors:
Wan, XS
Ware, JH
Zhang, LL
Newberne, PM
Evans, SM
Clark, LC
Kennedy, AR
Citation: Xs. Wan et al., Treatment with soybean-derived Bowman Birk inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice, PROSTATE, 41(4), 1999, pp. 243-252
Authors:
Mitsumori, K
Terai, A
Oka, H
Segawa, T
Ogura, K
Yoshida, O
Ogawa, O
Citation: K. Mitsumori et al., Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): Correlation with adenoma growth, PROSTATE, 41(4), 1999, pp. 253-257
Authors:
Malavaud, B
Miedouge, M
Payen, JL
Izopet, J
Rischmann, P
Pascal, JP
Sarramon, JP
Serre, G
Citation: B. Malavaud et al., Prostate-specific antigen in acute hepatitis and hepatocellular carcinoma, PROSTATE, 41(4), 1999, pp. 258-262
Authors:
Farnsworth, WE
Citation: We. Farnsworth, Estrogen in the etiopathogenesis of BPH, PROSTATE, 41(4), 1999, pp. 263-274
Authors:
Walker-Daniels, J
Coffman, K
Azimi, M
Rhim, JS
Bostwick, DG
Snyder, P
Kerns, BJ
Waters, DJ
Kinch, MS
Citation: J. Walker-daniels et al., Overexpression of the EphA2 tyrosine kinase in prostate cancer, PROSTATE, 41(4), 1999, pp. 275-280
Authors:
Nishimura, K
Kitamura, M
Miura, H
Nonomura, N
Takada, S
Takahara, S
Matsumoto, K
Nakamura, T
Matsumiya, K
Citation: K. Nishimura et al., Prostate stromal cell-derived hepatocyte growth factor induces invasion ofprostate cancer cell line DU145 through tumor-stromal interaction, PROSTATE, 41(3), 1999, pp. 145-153
Authors:
Hedlund, TE
Duke, RC
Miller, GJ
Citation: Te. Hedlund et al., Three-dimensional spheroid cultures of human prostate cancer cell lines, PROSTATE, 41(3), 1999, pp. 154-165
Authors:
Khoo, VS
Pollack, A
Cowen, D
Joon, DL
Patel, N
Terry, NHA
Zagars, GK
von Eschenbach, AC
Meistrich, ML
Troncoso, P
Citation: Vs. Khoo et al., Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy, PROSTATE, 41(3), 1999, pp. 166-172
Authors:
Ravindranath, N
Dym, M
Citation: N. Ravindranath et M. Dym, Isolation of rat ventral prostate basal and luminal epithelial cells by the STAPUT technique, PROSTATE, 41(3), 1999, pp. 173-180
Authors:
Konety, BR
Nangia, AK
Nguyen, TST
Thomas, A
Getzenberg, RH
Citation: Br. Konety et al., Effect of prenatal vitamin D (calcitriol) exposure on the growth and development of the prostate, PROSTATE, 41(3), 1999, pp. 181-189
Authors:
Hyytinen, ER
Frierson, HF
Sipe, TW
Li, CL
Degeorges, A
Sikes, RA
Chung, LWK
Dong, JT
Citation: Er. Hyytinen et al., Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer, PROSTATE, 41(3), 1999, pp. 190-195
Authors:
Garrett, SH
Sens, MA
Shukla, D
Nestor, S
Somji, S
Todd, JH
Sens, DA
Citation: Sh. Garrett et al., Metallothionein isoform 3 expression in the human prostate and cancer-derived cell lines, PROSTATE, 41(3), 1999, pp. 196-202
Authors:
Sreenath, T
Orosz, A
Fujita, K
Bieberich, CJ
Citation: T. Sreenath et al., Androgen-independent expression of hoxb-13 in the mouse prostate, PROSTATE, 41(3), 1999, pp. 203-207
Authors:
D'Amico, AV
Debruyne, F
Huland, H
Richie, JP
Citation: Av. D'Amico et al., Innovative treatment for clinically localized adenocarcinoma of the prostate: The future role of molecular imaging, PROSTATE, 41(3), 1999, pp. 208-212
Authors:
Theyer, G
Durer, A
Theyer, U
Haberl, I
Ulsperger, E
Baumgartner, G
Hamilton, G
Citation: G. Theyer et al., Measurements of free and total PSA, tissue polypeptide-specific antigen (TPS), and CYFRA 21-1 in prostate cancer patients under intermittent androgensuppression therapy, PROSTATE, 41(2), 1999, pp. 71-77